
Adipogen/NpFlamma® HGC ICG/BCT-PNC1501-Q250/250 doses
商品编号:
BCT-PNC1501-Q250
品牌:
Adipogen Inc
市场价:
¥129720.00
美元价:
77832.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Product Details | |
---|---|
Product Type | Chemical |
Properties | |
Source/Host Chemicals | Synthetic. |
Purity Chemicals | >95% (TLC) |
Appearance | Green solid. |
Solubility | Soluble in DMSO or water. |
Declaration | Manufactured by BioActs. |
Other Product Data |
Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Handling Advice |
Keep cool and dry. Protect from light. |
Use/Stability | Stable for at least 2 years after receipt when stored at +4°C. |
Documents | |
MSDS |
![]() |
Product Specification Sheet | |
Datasheet |
![]() |
NpFlamma® HGC ICG is a near-infrared fluorescent contrast agent that can be used for in vivo and can be utilized in angiography and tumor imaging of passive targeting by tail vein injection. NpFlamma® HGC ICG is a colloid-size nanoparticle based on the combination of chitosan and Flamma® NIR ICG which is a near-infrared fluorescent dye, and hydrophobic interior of NpFlamma® HGC can embed hydrophobic drugs. In conjunction with the effect of passive targeting, it can be utilized in efficient transport of drugs for tumor. Furthermore, carboxyl group on surface of NpFlamma® HGC ICG is developed to label proteome such as peptide and antibody or organic molecule such as amine. Due to advanced fluorescence technology of Flamma® NIR ICG, NpFlamma® that results more effective research imaging has almost no toxicity and pharmacological adverse drug reactions. Application Type: In vivo. Fluorescent agent type: Vascular, Passive targeted. Particle size: 250 nm. Fluorophore Label: ICG. Excitation ? Emission (nm): 785 / 821 nm.
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们